10X Genomics Inc vs Verizon Communications Inc — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Verizon Communications Inc trades at $43.75 (market cap $181.64B). The key difference: Verizon Communications Inc is far larger — about 33.1× 10X Genomics Inc's market cap, and Verizon Communications Inc pays a 6.51% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | VZ | |
|---|---|---|
Market Cap | $5.48B | $181.64B |
Sector | Health | Media |
52-Week High | $45.80 | $51.38 |
52-Week Low | $11.34 | $38.40 |
Enterprise Value | $5.02B | $369.14B |
Volume | — | 22,584,735 |
Dividend Yield | — | 6.51% |
Trailing returns across standard periods
Latest headlines on both assets
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →